Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Activating chimeric receptors and uses thereof in natural killer cell immunotherapy

Activating chimeric receptors and uses thereof in natural killer cell immunotherapy

US Patent 12258381 · Granted Mar 25, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method to specifically stimulate survival and expansion of genetically-modified 2025
T cell receptor-deficient chimeric antigen receptor T-cells and methods of use t2025
Neutralization of human cytokines with membrane-bound anti-cytokine non-signalin2025
Methods for enhancing efficacy of therapeutic immune cells2025
Methods for enhancing efficacy of therapeutic immune cells2025
Immune cells comprising truncated NKG2D chimeric receptors2025
Immune cells comprising truncated NKG2D chimeric receptors2025
Natural killer cells expressing membrane-bound interleukin 15 (mbIL15) and uses 2025
Blockade of CD2 surface expression and expression of chimeric antigen receptors 2024
Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T2024
Stimulatory cell lines for ex vivo expansion and activation of natural killer ce2024
Chimeric receptor with NKG2D specificity for use in cell therapy against cancer 2024